STOCK TITAN

Yubo Intl Biotech A (YBGJ) Stock Price, News & Analysis

YBGJ OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
26 41 sessions, November 3, 2025 to October 29, 2026
Largest daily move
+120.4% close of September 2, 2026
1-month change
-50% closing prices, September 23, 2026 to October 29, 2026

Company Description

Yubo Intl Biotech A (OTC: YBGJ) is classified in the medical instruments & supplies industry within the Healthcare sector and carries a market capitalization of $920.3K.

YBGJ declined 50.0% in the month to October 29, 2026. The last closing price was $0.0054.

For FY2025, Yubo Intl Biotech A reported revenue of $12K with net income of -$1.1M and diluted earnings per share of -$0.01.

This page collects what Stock Titan holds for YBGJ, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

$0.0054
No recent trading
Last close: October 29, 2026
-50%
1 month to October 29, 2026
$920.3K

Yubo Intl Biotech A (YBGJ) closed at $0.0054 on October 29, 2026. In the month to October 29, 2026, the price lost 50.0%.

See what a $1,000 investment in YBGJ would be worth today

Average down calculator for YBGJ

YBGJ Metrics & Rankings

Market Cap
$920.3K
View ranking

Price returns through October 29, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for YBGJ.

Financial Highlights

Yubo Intl Biotech A generated $12K in revenue in FY2025, retaining a 66.1% gross margin, operating income reached -$1.2M, and net income was -$1.1M. Diluted earnings per share stood at -$0.01. The company generated -$843K in operating cash flow. The current ratio was 0.24, measuring current assets divided by current liabilities.

$12K
Revenue (FY2025)
-$1.1M
Net Income (FY2025)
-$843K
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for YBGJ.

Short Interest History

Last 12 Months

Short interest in Yubo Intl Biotech A (YBGJ) currently stands at 114 shares, representing 0.0% of the float.

Days to Cover History

Last 12 Months

Days to cover for Yubo Intl Biotech A (YBGJ) currently stands at 114.0 days, up 11300% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 11300%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.

YBGJ Company Profile & Sector Positioning

Yubo Intl Biotech A (YBGJ) operates in the Medical Instruments & Supplies industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing YBGJ often look at related companies in the same sector, including Standard Dental Labs Inc (TUTH), BioLife Sciences Inc (BLFE), Reflect Scientific Inc (RSCF), Encision Inc (ECIA), and Cardiac Biotech Solution (CBSC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate YBGJ's relative position within its industry.

Frequently Asked Questions

Yubo Intl Biotech A (YBGJ) has no recent trading. Its last close was $0.0054 on October 29, 2026.

The market cap of Yubo Intl Biotech A (YBGJ) is approximately $920.3K. Learn more about what market capitalization means .

The FY2025 revenue of Yubo Intl Biotech A (YBGJ) is $12K, from its most recent completed fiscal year.

The FY2025 net income of Yubo Intl Biotech A (YBGJ) is -$1.1M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Yubo Intl Biotech A (YBGJ) is -$0.01 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Yubo Intl Biotech A (YBGJ) is -$843K for FY2025, its most recent completed fiscal year. Learn about cash flow.

The gross profit margin of Yubo Intl Biotech A (YBGJ) is 66.1% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Yubo Intl Biotech A (YBGJ), current assets divided by current liabilities, was 0.24 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Yubo Intl Biotech A (YBGJ) is $8K for FY2025, its most recent completed fiscal year.

The operating income of Yubo Intl Biotech A (YBGJ) is -$1.2M for FY2025, its most recent completed fiscal year. Learn about operating income.